Company Profile

Tissue Technologies LLC (AKA: Tissue Technologies LLC~Bio-Sense Inc)
Profile last edited on: 6/21/19      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2001
First Award
2002
Latest Award
2006
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

800 East Leigh Street Suite 56
Richmond, VA 23219
   (804) 225-0655
   kelmanc@comcast.net
   N/A
Location: Single
Congr. District: 04
County: Richmond city

Public Profile

Tissue Technologies, LLC focuses on the fabrication of "living" body parts without the use of genetic engineering or transgenic animals. In July 2006 the firm's first product, a dressing used to treat chronic wounds, was approved by the Food and Drug Administration. Tissue Technologies' dressing is different from typical gauze bandages in its proposed ability to interact with proteases, enzymes that are found in chronic wounds at high concentrations. Proteases play an important role in regulating the balance between tissue synthesis and degradation. However, in chronic wounds this regulation may be defective, resulting in substantial healing problems. Specifically, high protease levels in chronic wound fluid delays the wound healing process by degrading newly formed tissue and growth factor proteins. With initial FDA approval granted, Tissue Technologies will now work to prove their product promotes healing by eliminating the elevated levels of protease in chronic wound fluid. In addition to its protease inhibiting bandage, Tissue Technologies is developing products that prevent chronic wounds before they occur as well as a diagnostic strip that will allow nurses to determine protease levels in wound fluid with a “litmus”-type dipping str

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2006 1 NIH $118,604
Project Title: Protease Indicator for Chronic Wound Management
2005 2 NIH $1,253,986
Project Title: Modified Cotton Dressings for Treating Chronic Wounds

Key People / Management

  I Kelman Cohen -- President

  Yousef Mohjjer -- Vice President

Company News

There are no news available.